Volume 3 - Issue 6 - Nov/Dec 2006

Frank J. Criado, MD

I must say it was heartening to hear the many nice comments on my last Editor’s Corner in the September/October issue. And while wanting to believe such reactions were prompted by my sharp pen and lofty writing… I know better than that! Instead, I’… | Read More

Christian Spies, MD and R. Jeffrey Snell, MD

Introduction The prevalence of peripheral arterial disease (PAD) in the adult population is as high as 12–18%.1,2 Conservative treatments, including risk factor modification, supervised exercise training and medical therapy are indicated in patients… | Read More

Shahrzad Shareghi, MD and David M. Shavelle, MD

Case Report The use of vascular closure devices has dramatically increased in recent years in an attempt to reduce access site complications, patient discomfort and duration of immobilization.1 Three Food and Drug Administration (FDA)-approved… | Read More

Akio Kawamura, MD, Thomas C. Piemonte, MD, Richard W. Nesto, MD, Seth D. Bilazarian, MD, Nabila S. Riskalla, RN, Manish S. Chauhan, MD

Abstract Background. Percutaneous peripheral arterial intervention (PPAI) has emerged as an effective and less invasive alternative to surgery for peripheral arterial disease (PAD), however, data on gender differences in outcome of PPAI, especially… | Read More

Peter L. Faries, MD, Susan M. Trocciola, MD, Brian DeRubertis, MD, Robert L. Hynececk, MD, K. Craig Kent, MD

Abstract Objective. Continued expansion of abdominal aortic aneurysms (AAA) in the absence of an endoleak is thought to result from endotension. It has been observed more frequently with porous polytetrafluoroethylene (ePTFE) stent grafts and may be… | Read More

Ellen D. Dillavou, MD

Introduction Significant advances in the management of AAA have been made in the last decade, including the introduction of new endovascular treatment modalities (EVAR), screening studies and randomized trials to refine the appropriate timing of… | Read More

Frank J. Arena

Abstract Objective. To identify a new angiographic parameter associated with poor short- and long-term outcomes with nitinol stenting in the larger infrainguinal arteries. Background. Nitinol stents have proven to be useful and safe, but imperfect,… | Read More

Subbarao Myla, MD, FACC

Can you talk about the value of a comprehensive clinical program for the treatment of carotid artery disease (CAD)? How important is a thorough body of evidence? A rigorous clinical program for the treatment of CAD provides physicians with a… | Read More